Evaluation of the Transition Patient for GH Replacement
Track
:
CLINICAL
Program Code:
M07
Date:
Saturday, June 4, 2011
Time:
2:45 PM to 3:30 PM
EST
Location:
102AB
SPEAKER
:
Gudmundur Johannsson, MD,PHD, Sahlgrenska Univ Hosp Disclosures: GJ: Speaker, Eli Lilly & Company, Merck Serono; Clinical Researcher, Novo Nordisk, Pfizer, Inc.; Advisory Group Member, Otsuka; Chief Scientific Officer, DuoCort Pharma
Gudmundur Johannsson is Head of the Department of Endocrinology at Sahlgrenska University Hospital, and a professor of Endocrinology at the Sahlgrenska Academy, University of Gothenburg, Sweden. He received medical education at the University of Iceland and training in internal medicine and clinical endocrinology at Sahlgrenska University Hospital, Gothenburg Sweden. He defended his thesis in 1997, became senior lecturer in 2003 and professor of endocrinology in 2009 at the Sahlgrenska Academy, University of Gothenburg. Major research interest is pituitary diseases, the importance of growth hormone in adults and adrenal insufficiency.